Description
This report presents a detailed, data-driven analysis of the global Cell and Gene Therapy Supply Chain Software Market size, offering insights into historical performance, current dynamics, and projections from 2025 to 2035. With a strong emphasis on factual assessment, the report refrains from speculative assumptions and aims to support business decisions through accurate forecasting and strategic intelligence.
I recently came across a report by Roots Analysis that really put things into perspective. According to them, The global cell and gene therapy supply chain software market, valued at USD 312 million in 2025, is projected to reach USD 356 million in 2026 and USD 1,329 million by 2035, representing a CAGR of 15.8% during the forecast period 2026 to 2035.
Market Segmentation
- Historical Trend: Since 2019
- Base Year: 2023
- Forecast Period: Till 2035
- Market Size 2026: USD 356 million
- Market Size 2035: USD 1,329 million
- CAGR (Till 2035): 15.8%
- Process Component
• Sample Collection and Processing Component
• Manufacturing Component
• Logistics Component
• Patient Identification and Treatment Follow-up Component
- Type of Software
• Enterprise Manufacturing System (EMS)
• Laboratory Information Management System (LIMS)
• Inventory Management System (IMS)
• Cell Orchestration Platform (COP)
• Quality Management System (QMS)
• Logistics Management System (LMS)
• Patient Management System (PMS)
- Mode of Deployment
• On-premises Deployment
• Cloud-based Deployment
- Type of End-User
• Pharmaceutical Companies
• Cell Therapy Labs
• Hospitals / Medical Centers
• Research Institutes / Biobanks
- Scale of Operation
• Clinical Scale
• Commercial Scale
- Geography
• North America
• Europe
• Asia-Pacific
• Rest of the World
- Key Companies Profiled
• Azenta Life Sciences
• Biocair
• BioLife Solutions
• CareDx
• Cryoport
• Lonza
• NMDP BioTherapies
• TraceLink
• TrakCel
• Veeva Systems
• Emerson
• LabVantage Solutions
• Marken
• MasterControl
• QuickSTAT
• Siemens
• Stafa Cellular Therapy
• Steiner
• STEMSOFT Software
• TECHNIDATA
• Thermo Fisher Scientific
- PowerPoint Presentation(Complimentary): Available
- Customization scope: 15% Free Customization
- Excel Data Packs (Complimentary)
• Market Landscape Analysis
• Company Competitiveness Analysis
• Funding and Investment Analysis
• Partnership and Collaborations Analysis
• Platform Utilization Cases Analysis
• Market Size an Opportunity Analysis
Read More: https://www.rootsanalysis.com/reports/cell-therapies-supply-chain/260.html
Key Geographies
- North America
- Europe
- Asia-Pacific
- Middle East and North Africa
- Latin America
Each segment is analyzed by volume, value, and growth patterns, offering a comparative understanding of usage trends and market opportunities.
Cell and Gene Therapy Supply Chain Software Market Share Insights
▪ Cell and Gene Therapy Supply Chain Software Market: Report Attributes / Market Segmentations
Analytical Insights Covered
▪ Market Landscape Analysis
▪ Company Competitiveness Analysis
▪ Funding and Investment Analysis
▪ Partnership and Collaborations Analysis
▪ Platform Utilization Cases Analysis
▪ Market Size an Opportunity Analysis
Key Players Include:
- Andermatt
- Bayer
- BioSafe Systems
- Certis Biologicals
- Corteva Agriscience
- Novozymes
- Nutri-Tech Solutions
- ProFarm
- Syngenta
- Valent Biosciences
These companies are assessed based on their contributions to market share, innovation, and responsiveness to global and regional demand shifts.
Regional Insights
Each region is evaluated based on:
- Historical market trends and sales data
- Regulatory frameworks
- Product availability and distribution strength
- Emerging opportunities and constraints
Comparative regional analysis enables better targeting of expansion strategies and investment planning.
Supply Chain & Operational Overview
This section covers:
- Pricing structures
- Distribution channels
- Manufacturing capabilities
- Cost breakdowns and logistics trends
Understanding operational flows adds value to strategic sourcing and capacity expansion discussions.
Research Methodology
This report is developed using a combination of:
- Primary research: Expert interviews, corporate disclosures
- Secondary research: Company websites, public filings, databases, and published literature
All data points were reviewed for consistency, ensuring neutrality, reliability, and practical relevance for stakeholders and strategic planners.
Conclusion and Customization
This Cell and Gene Therapy Supply Chain Software Market report serves as a foundational reference for:
- Market entry and expansion strategies
- Product development roadmaps
- Investment decision-making
For custom data slices or tailored analysis by geography, product, or competitor, please contact [email protected].